These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28366534)

  • 1. SMA mutations in SMN Tudor and C-terminal domains destabilize the protein.
    Takarada T; Ar Rochmah M; Harahap NIF; Shinohara M; Saito T; Saito K; Lai PS; Bouike Y; Takeshima Y; Awano H; Morioka I; Iijima K; Nishio H; Takeuchi A
    Brain Dev; 2017 Aug; 39(7):606-612. PubMed ID: 28366534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutation analysis of SMN1 gene in patients with spinal muscular atrophy].
    DU J; Qu YJ; Xiong H; Li EZ; Jin YW; Bai JL; Wang H; Song F
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):411-5. PubMed ID: 21924051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypes of SMA patients retaining SMN1 with intragenic mutation.
    Wijaya YOS; Ar Rohmah M; Niba ETE; Morisada N; Noguchi Y; Hidaka Y; Ozasa S; Inoue T; Shimazu T; Takahashi Y; Tozawa T; Chiyonobu T; Inoue T; Shiroshita T; Yokoyama A; Okamoto K; Awano H; Takeshima Y; Saito T; Saito K; Nishio H; Shinohara M
    Brain Dev; 2021 Aug; 43(7):745-758. PubMed ID: 33892995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.
    Yamada H; Nishida Y; Maihara T; Sa'adah N; Harahap NI; Nurputra DK; Ar Rochmah M; Nishimura N; Saito T; Kubo Y; Saito K; Nishio H
    Pediatr Neurol; 2015 Jun; 52(6):638-41. PubMed ID: 25838041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy.
    Niba ETE; Nishio H; Wijaya YOS; Ar Rochmah M; Takarada T; Takeuchi A; Kimizu T; Okamoto K; Saito T; Awano H; Takeshima Y; Shinohara M
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T; Sato H; Lai PS; Nurputra DK; Harahap NI; Morikawa S; Nishimura N; Kurashige T; Ohshita T; Nakajima H; Yamada H; Nishida Y; Toda S; Takanashi J; Takeuchi A; Tohyama Y; Kubo Y; Saito K; Takeshima Y; Matsuo M; Nishio H
    Brain Dev; 2014 Nov; 36(10):914-20. PubMed ID: 24359787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of SMN gene in Chinese children with spinal muscular atrophy].
    Liu WL; Li F; Ma HW; Li HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):539-43. PubMed ID: 20637152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing.
    Kubo Y; Nishio H; Saito K
    J Hum Genet; 2015 May; 60(5):233-9. PubMed ID: 25716911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal muscular atrophy pathogenic mutations impair the axonogenic properties of axonal-survival of motor neuron.
    Locatelli D; d'Errico P; Capra S; Finardi A; Colciaghi F; Setola V; Terao M; Garattini E; Battaglia G
    J Neurochem; 2012 May; 121(3):465-74. PubMed ID: 22324632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations.
    Martín Y; Valero A; del Castillo E; Pascual SI; Hernández-Chico C
    Hum Genet; 2002 Mar; 110(3):257-63. PubMed ID: 11935338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins.
    Kotani T; Sutomo R; Sasongko TH; Sadewa AH; Gunadi ; Minato T; Fujii E; Endo S; Lee MJ; Ayaki H; Harada Y; Matsuo M; Nishio H
    J Neurol; 2007 May; 254(5):624-30. PubMed ID: 17415510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c.835-5T>G Variant in SMN1 Gene Causes Transcript Exclusion of Exon 7 and Spinal Muscular Atrophy.
    Wu S; Li YL; Cheng NY; Wang C; Dong EL; Lu YQ; Li JJ; Guo XX; Lin X; Lai LL; Liu ZW; Wang N; Chen WJ
    J Mol Neurosci; 2018 Jun; 65(2):196-202. PubMed ID: 29799103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Mechanism of a New SMN1 Variant (c.835G>C, p.Gly279Arg) by Interrupting Exon 7 Skipping and YG Oligomerization in Causation of Spinal Muscular Atrophy.
    Bai J; Qu Y; Song F; Cao Y; Cheng M; Wang J; Jin Y; Wang H
    J Mol Neurosci; 2021 Jan; 71(1):112-121. PubMed ID: 32812185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy.
    Brichta L; Garbes L; Jedrzejowska M; Grellscheid SN; Holker I; Zimmermann K; Wirth B
    Hum Genet; 2008 Mar; 123(2):141-53. PubMed ID: 18172693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype relationship in 2 SMA III patients with novel mutations in the Tudor domain.
    Fraidakis MJ; Drunat S; Maisonobe T; Gerard B; Pradat PF; Meininger V; Salachas F
    Neurology; 2012 Feb; 78(8):551-6. PubMed ID: 22323744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the SMN gene mutations in spinal muscular atrophy patients in China.
    Liu WL; Li F; He ZX; Ai R; Ma HW
    Genet Mol Res; 2013 Sep; 12(3):3598-604. PubMed ID: 24085424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation analysis of SMN gene in a patient and his family with spinal muscular atrophy].
    Zeng J; Lin YH; Yan AZ; Cai MY; Ke LF; Lan FH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):139-43. PubMed ID: 19350502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal muscular atrophy caused by a novel Alu-mediated deletion of exons 2a-5 in SMN1 undetectable with routine genetic testing.
    Jedličková I; Přistoupilová A; Nosková L; Majer F; Stránecký V; Hartmannová H; Hodaňová K; Trešlová H; Hýblová M; Solár P; Minárik G; Giertlová M; Kmoch S
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1238. PubMed ID: 32337852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
    Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
    Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.